Catheter Precision shares surge 12.59% after-hours as CMS adds EP ablation codes to ASC list, expanding LockeT commercialization.

Catheter Precision (VTAK) surged 12.59% in after-hours trading following the announcement that the Centers for Medicare and Medicaid Services (CMS) will add electrophysiology (EP) ablation procedures to the Ambulatory Surgery Center-Covered Procedures List (ASC-CPL) effective January 1, 2026. This policy change expands access to EP services for Medicare beneficiaries and creates a commercialization opportunity for the company’s LockeT suture retention device, which aids in rapid hemostasis and same-day discharge. The CEO highlighted that ASCs prioritize cost-effective, workflow-efficient solutions, aligning with LockeT’s value proposition. The news underscores potential for increased patient scheduling and adoption of LockeT in new ASC facilities, positioning the device as a key beneficiary of the regulatory shift.